[CNBC] The $84,000 question: Will focusing on drug prices rein in costs?

By Meg Tirrell May 22, 2014   The mounting scrutiny of prescription drug prices in the U.S. reached fever pitch when a new drug for hepatitis […]

Read more

[Politico] No consensus on how to afford specialty drugs

By Brett Norman May 21, 2014 The astronomical price of a new “miracle” drug for hepatitis C has insurers and others who ultimately foot health care […]

Read more

[Healthcare Payer News] Sovaldi spurs call to action on high drug costs

By Anthony Brino May 21, 2014   The breakthrough hepatitis drug Sovaldi has sparked a vigorous debate about the financial sustainability of U.S. healthcare and the […]

Read more

[Law360] Drugmakers, Insurers Battle Over Surging Big Pharma Prices

By Jeff Overly May 21, 2014   Executives representing drugmakers, employers and health insurers sparred Wednesday at a high-profile forum on soaring prescription drug prices, clashing […]

Read more